Alkermes plc Stock
Alkermes plc Stock
Heavy losses for Alkermes plc today as the stock fell by -€1.390 (-4.700%).
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Alkermes plc.
With a target price of 37 € there is a positive potential of 31.16% for Alkermes plc compared to the current price of 28.21 €.
Pros and Cons of Alkermes plc in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alkermes plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Alkermes plc | -4.700% | -5.967% | 19.534% | 19.534% | 19.534% | 6.856% | 77.421% |
| Icon plc | 0.860% | -5.526% | -0.958% | -28.378% | -41.297% | -52.834% | - |
| United Therapeutics | -1.530% | -0.429% | 3.615% | 96.730% | 14.042% | 134.957% | 184.971% |
| Ionis Pharmaceuticals Inc. | -1.960% | -1.110% | -0.804% | 169.073% | -5.650% | 87.980% | 80.264% |
Comments
Alkermes (ALKS) had its price target lowered by Piper Sandler from $45.00 to $43.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes (ALKS) had its price target lowered by Royal Bank Of Canada from $47.00 to $45.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes (ALKS) had its price target raised by Wells Fargo & Company from $37.00 to $43.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat